Furthermore, there were no statistically significant changes in the use of only insulin therapy during the follow-up among all patient groups, except those with T2D + CVD + AMD, who showed an increasing trend in the use of only insulin therapy (Table 2). This evidence concerns the gene INS and age-related macular degeneration.